Cyanine5 NHS ester minimal dye

NHS esters Cyanine5 Protein labeling
Cat. # Quantity Price Lead time
1C041 5 nmol $110 in stock
2C041 10 nmol $175 in stock
3C041 25 nmol $265 in stock
Bulk inquiry
Found better price? Let us know and we will propose the way forward!

Cyanine5 minimal dye for protein labeling, an analog of Cy5® minimal dye.

This reagent is specially quantified for the use in 2D proteomics. Each package contains specified amount of NHS ester with quantity variation within 10%.

Cyanine5 NHS ester minimal dye, 3C041
Cyanine5 NHS ester minimal dye, 3C041
Cyanine5 NHS ester minimal dye, 3C041

Customers also purchased with this product

Cyanine3 carboxylic acid

The free carboxylic acid of Cyanine3 dye. Non-sulfonated dye, with good solubility in organic solvents, and limited aqueous solubility.

Cyanine3 hydrazide

Cyanine3 hydrazide is a carbonyl-reactive dye for Cy3 channel.

Cyanine7.5 carboxylic acid

Cyanine7.5 carboxylic acid - unactivated NIR cyanine dye carboxylic acid.
Add this product to your cart and
get free express delivery

General properties

Appearance: dark blue solid
Mass spec M+ increment: 580.73
Molecular weight: 667.54
Molecular formula: C36H42BF4N3O4
Solubility: soluble in polar organic solvents
Quality control: NMR 1H, HPLC-MS, functional testing
Storage conditions: Storage: 12 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate.
MSDS: Download
Product specifications

Spectral properties

Excitation/absorption maximum, nm: 646
Emission maximum, nm: 662
CF260: 0.03
CF280: 0.04

Product citations

  1. Miltner, N.; Kalló, G.; Csősz, É.; Miczi, M.; Nagy, T.; Mahdi, M.; Mótyán, J. A.; Tőzsér, J. Identification of SARS-CoV-2 Main Protease (Mpro) Cleavage Sites Using Two-Dimensional Electrophoresis and In Silico Cleavage Site Prediction. International Journal of Molecular Sciences, 2023, 24(4), 3236. doi: 10.3390/ijms24043236
  2. Ryabchevskaya, E. M.; Granovskiy, D. L.; Evtushenko, E. A.; Ivanov, P. A.; Kondakova, O. A.; Nikitin, N. A.; Karpova, O. V. Designing Stable Bacillus Anthracis Antigens with a View to Recombinant Anthrax Vaccine Development. Pharmaceutics, 2022, 14(4), 806. doi: 10.3390/pharmaceutics14040806
  3. Yu, W.; Bosquée, E.; Fan, J.; Liu, Y.; Bragard, C.; Francis, F.; Chen, J. Proteomic and Transcriptomic Analysis for Identification of Endosymbiotic Bacteria Associated with BYDV Transmission Efficiency by Sitobion miscanthi. Plants, 2022, 11(23), 3352. doi: 10.3390/plants11233352
  4. Pletnev, P. I.; Shulenina, O.; Evfratov, S.; Treshin, V.; Subach, M. F.; Serebryakova, M. V.; Osterman, I. A.; Paleskava, A.; Bogdanov, A. A.; Dontsova, O. A.; Konevega, A. L.; Sergiev, P. V. Ribosomal Protein S18 Acetyltransferase RimI Is Responsible for the Acetylation of Elongation Factor Tu. Journal of Biological Chemistry, 2022, 298(5), 101914. doi: 10.1016/j.jbc.2022.101914
Show more (42)

Cy® is a trademark of GE Healthcare.

Purchase of these products does not imply transfer of license to perform methods patented by Carnegie Mellon University covered by US patents 6,043,025, 6,127,134, 6,246,190, 7566,544, and 7,598,047 "Difference gel electrophoresis using matched multiple dyes" and family members in Australia, Canada, Europe and Japan.

This Product is offered and sold for research purposes only. It has not been tested for safety and efficacy in food, drug, medical device, cosmetic, commercial or any other use. Supply does not express or imply authorization to use for any other purpose, including, without limitation, in vitro diagnostic purposes, in the manufacture of food or pharmaceutical products, in medical devices or in cosmetic products.
Your item has been added. View your cart or proceed to checkout
The count of items is incorrect.